Cadila Group receives USFDA approval for Clindamycin Phosphate and Benzoyl Peroxide

Zydus Cadila has received the final USFDA approval to market Clindamycin Phosphate and Benzoyl Peroxide gel in US markets.

The combination gel is used in the treatment of acne. It also helps to decrease the number of acne pimples. It will be at the group’s topical manufacturing facility at Ahmedabad.

Company Profile : Cadila Healthcare Ltd

Be the first to comment

Leave a Reply

Your email address will not be published.


*